LUCID DIAGNOSTICS
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company. Lucid is focused on the millions of patients with gastroesophageal disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid’s EsoGuard® Esophageal DNA Test, performed on samples collected in a brief noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, is the first and only commercially available diagnostic test capable of serving as a widespread screening tool to prevent cancer and cancer deaths through early detection of esophageal precancer in at-risk GERD patients.
LUCID DIAGNOSTICS
Industry:
Health Care Health Diagnostics Therapeutics
Founded:
2018-05-30
Status:
Active
Contact:
2129494319
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Apache Euro Amazon GStatic Google Static Content COVID-19
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-07 | CapNostics | CapNostics acquired by Lucid Diagnostics | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-21 | Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer |
More informations about "Lucid Diagnostics"
Lucid Diagnostic Investor Relations - Overview
Apr 30, 2025 Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today …See details»
Who we are - LucidDX
At Lucid Diagnostics, we believe early detection will make esophageal cancer a disease of the past. We're using targeted next generation sequencing to fundamentally change the way esophageal precancer is detected. Join a …See details»
Lucid Diagnostics Launches New Corporate Website
Jul 11, 2024 About Lucid Diagnostics Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients …See details»
Lucid Diagnostic Investor Relations - Board of Directors
Ronald M. Sparks. Director. Ronald M. Sparks has served as a member of PAVmed’s board of directors since January 2015. Mr. Sparks has more than 42 years of executive experience in …See details»
Leadership [CMS] - luciddx.com
Lucid Diagnostics Corporate Headquarters 360 Madison Ave, Floor 25 New York, NY 10017. Lucid Dx Labs 14 Orchard Road Lake Forest, CA 92630. Email [email protected]. Phone …See details»
LUCID DIAGNOSTICS INC. - Crunchbase Company …
Lucid Diagnostics is a commercial-stage, cancer-prevention medical diagnostics company. Lucid focuses on patients with gastroesophageal disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal …See details»
Lucid Diagnostics Launches New Corporate Website - PR Newswire
Jul 11, 2024 About Lucid Diagnostics Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). …See details»
Lucid Diagnostics Inc. (LUCD) - Yahoo Finance
See the company profile for Lucid Diagnostics Inc. (LUCD) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Lucid Diagnostics - Org Chart, Teams, Culture & Jobs - The Org
View Lucid Diagnostics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Lucid Diagnostics Launches New Corporate Website
Jul 11, 2024 Lucid Diagnostics disclaims any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in its expectations or in events, …See details»
LUCD - Lucid Diagnostics Inc. Latest Stock News & Market Updates
Apr 24, 2025 Operating as a subsidiary of a larger medical technology organization, Lucid Diagnostics generates revenue through multiple avenues including traditional claims …See details»
Lucid Diagnostics Inc. Company Profile & Executives - WSJ
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, …See details»
Careers - LucidDX
At Lucid Diagnostics, we believe early detection will make esophageal cancer a disease of the past. ... We uphold human rights standards and promote diversity, equity, and inclusion across …See details»
Lucid Diagnostics Provides Business Update and Reports First …
18 hours ago Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. Lucid is focused on the millions of …See details»
Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call …
1 day ago Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2025 Business Update Conference Call May 14, 2025 8:30 AM ETCompany Participants. Matt Riley – Senior Director-Investor …See details»
Lucid Diagnostics Provides Business Update and Preliminary …
Mar 25, 2024 About Lucid Diagnostics Lucid Diagnostics Inc. is a commercial-stage medical diagnostics company focused on cancer prevention, and subsidiary of PAVmed Inc. (Nasdaq: …See details»
Lucid Diagnostics Company Profile - Office Locations ... - Craft
Oct 29, 2024 Lucid Diagnostics $2.4 m in annual revenue in FY 2023. See insights on Lucid Diagnostics including office locations, competitors, revenue, financials, executives, …See details»
Lucid Diagnostics Announces Pricing of Public Offering of …
Apr 9, 2025 Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. …See details»
LUCID DIAGNOSTICS INC. - Funding, Financials, Valuation
Oct 13, 2021 LUCID DIAGNOSTICS INC. is registered under the ticker NASDAQ:LUCD . Their stock opened with $14.00 in its Oct 13, 2021 IPO. LUCID DIAGNOSTICS INC. is funded by …See details»
Newsroom - LucidDX
Lucid Diagnostics Corporate Headquarters 360 Madison Ave, Floor 25 New York, NY 10017. Lucid Dx Labs 14 Orchard Road Lake Forest, CA 92630. Email [email protected]. Phone …See details»